Pharmaceutical Industry Articles & Reports - Page 35

A 2025 overview of AI in radiology, covering FDA authorizations, clinical adoption rates, and key technologies from CNNs to foundation models for medical imaging.

Learn about the X12 EDI standard for electronic data interchange. Updated for 2026, this guide covers X12 Version 008060, common transaction sets (850, 837), HIPAA updates, EDI-API hybrid integration, and the $41B+ EDI market.

Learn the fundamentals of EDI mapping for CPG suppliers. This 2026-updated guide covers EDI standards (ANSI X12, EDIFACT), AI-driven mapping automation, hybrid EDI+API integration, and retailer compliance strategies.

Learn about Cohere Health, the health-tech firm using AI to automate prior authorization. Updated for 2026 with ZignaAI acquisition, record growth, and expanded platform coverage

Explore the difference between autonomous AI agents and structured AI workflows. Learn why deterministic AI pipelines dominate production deployments in 2025.

Learn how IBM Quantum is applied in pharmaceutical R&D. This guide covers molecular simulation, hybrid workflows, the Nighthawk and Starling processors, and key partnerships with Moderna, Algorithmiq, and Cleveland Clinic.

Learn how the Availity platform serves as an EDI gateway for payers. This 2026-updated analysis covers its FHIR solutions, Rapid Recovery cybersecurity, AI-powered prior authorization, and CMS-0057 compliance.

With the rise of vibe coding, many question Agile's future. Our analysis shows Agile remains crucial for managing risks and ensuring quality in AI-driven projec

Learn what a semantic layer is. This technical guide explains how it bridges data sources and BI tools, creating unified metrics and business-friendly data mode

A detailed 2025 analysis of the GxP managed services market for pharma & life sciences. Learn about trends, regulatory drivers, and GxP compliance challenges.

An in-depth analysis of the specialty pharmacy industry covering key players (PBMs, distributors), market trends, biosimilar competition, PBM reform, and the economics of high-cost specialty drugs. Updated March 2026.

Learn about the ANSI X12 EDI protocol. This guide explains the structure of X12 transaction sets, with a deep dive into healthcare's 270/271 and 278 transactions, including CMS-0057-F prior authorization mandates and the X12-to-FHIR transition

Learn why over 85% of clinical trials face delays. Updated for 2026, this analysis covers key scientific, operational, and regulatory challenges from Phase I to III, including site activation bottlenecks, AI-driven recruitment, and ICH E6(R3) GCP updates.

Learn the complete history of GLP-1 drugs from the incretin effect to 2026 breakthroughs. Covers exenatide, semaglutide, tirzepatide, oral Wegovy, retatrutide, CagriSema, and the evolution from diabetes to obesity treatment.

An in-depth guide to US drug formularies, pharmacy benefits, and prior authorization (PA). Learn how P&T committees, tiers, ePA systems, and the CMS-0057-F interoperability rule shape drug coverage and costs

Get a complete list of Real-Time Benefits Check (RTBC) modules and providers. Learn how solutions from Surescripts, DrFirst, Arrive Health (formerly RxRevu), GoodRx & more work within EHRs. Updated for 2026.

Learn what a health insurance formulary is. This guide explains the drug list, tiers, and cost-sharing used by PBMs to control prescription costs and access.

An evidence-based analysis of the top 5 electronic prior authorization (ePA) platforms. Compare CoverMyMeds, Surescripts, OptimizeRx, DrFirst & Availity — updated with 2025-2026 CMS-0057-F milestones, Touchless PA, and AI-driven workflows.

Learn about the NCPDP SCRIPT standard, the U.S. foundation for electronic prescribing (e-prescribing). Updated for 2026 with HTI-4 Final Rule, v2023011 migration, and latest Surescripts data.

A technical analysis of cost-effective LLMs (updated March 2026). Compare API pricing, performance benchmarks, and features for Gemini 3.1 Flash-Lite, Claude Haiku 4.5, GPT-5 Mini, Grok 4.1 Fast, DeepSeek V3.2, and more.

Learn the 9 ALCOA+ principles for GxP data integrity. Updated for 2026 with ICH E6(R3) finalization, EU GMP Chapter 4 ALCOA++ draft, and latest FDA enforcement trends

Explore Veeva QualityOne, the unified cloud QMS for regulated industries like CPG & chemicals. Updated for 2026 with AI Agents, LIMS, new modules, and customer case studies.

Full 2026 LLM API price comparison: GPT-5.2, Gemini 3.1 Pro, Claude Opus 4.6, Grok 4, and DeepSeek V3.2 costs per million tokens, updated February 2026.

An educational analysis of AI biotech funding in 2025. Explore venture capital investment trends, funding data, and key deals in AI for drug discovery.